High activity of the anti-IGF-IR antibody CP-751,871 in combination with paclitaxel and carboplatin in squamous NSCLC

被引：27

作者：

Karp, D. D.

Paz-Ares, L. G.

Novello, S.

Haluska, P.

Garland, L.

Cardenal, F.

Blakely, L. J.

Eisenberg, P. D.

Gualberto, A.

Langer, C. J.

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Hosp Univ Virgen del Rocio, Seville, Spain

[3] Univ Turin, Turin, Italy

[4] Mayo Clin, Rochester, MN USA

[5] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA

[6] Inst Catala Oncol, Barcelona, Spain

[7] West Clin, Memphis, TN USA

[8] Calif Canc Care, Greenbrae, CA USA

[9] Pfizer Global Res & Dev, New London, CT USA

[10] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA

来源：

关键词：

D O I：

10.1200/jco.2008.26.15_suppl.8015

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8015

引用

页数：1